Skip to content

Ketamine by intravenous, sublingual and oral route of administration for treatment of pain:pharmacokinetics

Ketmine by intravenous, sublingual and oral route of administration for treatment of pain: pharmacokinetics

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12605000220662
Enrollment
6
Registered
2005-08-26
Start date
2005-06-01
Completion date
2005-10-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Adminstration of oral, sublingual, intravenous ketamine for patints in acute pain.

Sponsors

Professor Stephan Schug
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Previously on ketamine.

Exclusion criteria

Coronary artery disease,hypertension,tachyarrythmias,impaired renal function,pregnancy,lactation.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026